BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9467796)

  • 1. Variability in treatment-seeking cocaine abusers: implications for clinical pharmacotherapy trials.
    Carroll KM; Nich C; Rounsaville BJ
    NIDA Res Monogr; 1997; 175():137-57. PubMed ID: 9467796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodologic recommendations for cocaine abuse clinical trials: a clinician-researcher's perspective.
    Nunes EV
    NIDA Res Monogr; 1997; 175():73-95. PubMed ID: 9467793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Addiction Severity Index in clinical efficacy trials of medications for cocaine dependence.
    Cacciola JS; Alterman AI; O'Brien CP; McLellan AT
    NIDA Res Monogr; 1997; 175():182-91. PubMed ID: 9467798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.
    Elkashef A; Holmes TH; Bloch DA; Shoptaw S; Kampman K; Reid MS; Somoza E; Ciraulo D; Rotrosen J; Leiderman D; Montgomery A; Vocci F
    Addiction; 2005 Mar; 100 Suppl 1():91-101. PubMed ID: 15730353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cocaine dependence and depression.
    Rounsaville BJ
    Biol Psychiatry; 2004 Nov; 56(10):803-9. PubMed ID: 15556126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of clinical trials with new medications for cocaine dependence and abuse.
    Kiev A
    NIDA Res Monogr; 1997; 175():96-117. PubMed ID: 9467794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From the initial clinic contact to aftercare: a brief review of effective strategies for retaining cocaine abusers in treatment.
    Higgins ST; Budney AJ
    NIDA Res Monogr; 1997; 165():25-43. PubMed ID: 9243545
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancing retention in clinical trials of psychosocial treatments: practical strategies.
    Carroll KM
    NIDA Res Monogr; 1997; 165():4-24. PubMed ID: 9243544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome measurement considerations: pharmacological treatments for substance abuse.
    Moras K
    NIDA Res Monogr; 1997; 175():118-36. PubMed ID: 9467795
    [No Abstract]   [Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of family intervention science.
    Diamond G; Siqueland L
    Child Adolesc Psychiatr Clin N Am; 2001 Jul; 10(3):641-61. PubMed ID: 11449817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research issues related to development of medications for treatment of cocaine addiction.
    Klein M
    Ann N Y Acad Sci; 1998 May; 844():75-91. PubMed ID: 9668666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
    McDowell D; Nunes EV; Seracini AM; Rothenberg J; Vosburg SK; Ma GJ; Petkova E
    Drug Alcohol Depend; 2005 Nov; 80(2):209-21. PubMed ID: 15913920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned.
    Kampman KM; Leiderman D; Holmes T; LoCastro J; Bloch DA; Reid MS; Shoptaw S; Montgomery MA; Winhusen TM; Somoza EC; Ciraulo DA; Elkashef A; Vocci F
    Addiction; 2005 Mar; 100 Suppl 1():102-10. PubMed ID: 15730354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurobehavioral treatment for cocaine dependency: a preliminary evaluation.
    Rawson RA; Obert JL; McCann MJ; Ling W
    NIDA Res Monogr; 1993; 135():92-115. PubMed ID: 8289906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
    Gillet C; Polard E; Mauduit N; Allain H
    Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment effectiveness score as an outcome measure in clinical trials.
    Ling W; Shoptaw S; Wesson D; Rawson RA; Compton M; Klett CJ
    NIDA Res Monogr; 1997; 175():208-20. PubMed ID: 9467800
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of depression--newer pharmacotherapies.
    Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
    Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosocial treatments for bipolar disorders.
    Scott J; Colom F
    Psychiatr Clin North Am; 2005 Jun; 28(2):371-84. PubMed ID: 15826737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.